SB 56 — AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.

UNOFFICIALCHAPTER COPY154 221 RSCHAPTER 154 ( SB 56/GA56 ) AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose.

of this Page 1 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA section shall serve terms concurrent with holding their respective offices or positions.

(5) The commission shall award moneys from the opioid abatement trust fund established in KRS 15.293 to reimburse prior expenses or to fund projects according to the following criteria related to opioid use disorder (OUD) or any co-co-occurring occurring substance use disorder or mental health (SUD/MH) issues:

Legislative Research Commission PDF Version ACTS OF THE GENERAL ASSEMBLY a.

Page 2 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA c.

Treatment, recovery, or other services provided by community health centers or not-for-profitnot-for- profit providers;

Supports crisis stabilization centers that serve as an alternative to hospital emergency departments for persons with OUD and any co-co-occurring Page 3 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA occurring SUD/MH issues or persons that have experienced an opioid overdose;

Improves oversight of opioid treatment programs to ensure evidence-evidence-based based and evidence-informedevidence- informed practices;

CHAPTER 154 3 14.

Page 4 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA 17.

Provides evidence-informed treatment, recovery support, harm reduction, or other appropriate services to individuals with OUD and any co-occurring SUD/MH issues who are incarcerated, leaving jail or Page 5 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA prison, have recently left jail or prison, are on probation or parole, are under community corrections supervision, or are in re-entry programs or facilities;

Legislative Research Commission PDF Version ACTS OF THE GENERAL ASSEMBLY Section 2.

Page 6 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA (a) Written or electronic educational materials on safe and proper disposal of hypodermic needles and syringes;

(2) A licensed health-care provider who, acting in good faith, directly or by standing order, prescribes or dispenses an opioid antagonist[the drug naloxone] to a person or agency who, in the judgment of the health-care provider, is capable of administering the drug for an emergency opioid overdose, shall not, as a result of his or her acts or omissions, be subject to disciplinary or other adverse action under KRS Chapter 311, 311A, 314, or 315 or any other professional licensing statute.

(3)[(2)] A prescription for an opioid antagonist[naloxone] may include authorization Page 7 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA for administration of the drug to the person for whom it is prescribed by a third party, if the prescribing instructions indicate the need for the third party, upon administering the drug, to immediately notify a local public safety answering point of the situation necessitating the administration.

(b) Possess an opioid antagonist [naloxone ]pursuant to this subsection and any equipment needed for its administration;[ and] (c) Administer an opioid antagonist[naloxone] to an individual suffering from an apparent opioid-related[opiate-related]opioid- related[opiate-related] overdose;

Require that any dispensing under this section be done only in accordance with a physician-approvedphysician- approved protocol and specify the Page 8 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA minimum required components of any such protocol;

CHAPTER 154 5 2.

(8)(7)](8)(7)]Notwithstanding Notwithstanding any provision of law to the contrary, a licensed health care provider, including a pharmacist who is utilizing a protocol established by this section, may[ pharmacist may utilize the protocol established by this section to] dispense an opioid antagonist[naloxone] to any person or agency who, as part of a harm reduction program, provides training to the public on the mechanism and Page 9 of 10 SB005610.100 - 187 - XXXX GA UNOFFICIAL COPY 22 RS SB 56/GA circumstances for the administration of an opioid antagonist[naloxone to the public as part of a harm reduction program], regardless of whom the ultimate user of the opioid antagonist[naloxone] may be.

PageSigned 10by ofGovernor 10April SB005610.1008, -2022. 187 - XXXX GA

Legislative Research Commission PDF Version